U.S. markets closed

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8900-0.0300 (-1.56%)
At close: 4:00PM EDT
1.8600 -0.03 (-1.59%)
After hours: 04:12PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
0
Operating Expense
4,057
2,552
2,086
2,314
2,365
Operating Income
-4,057
-2,552
-2,086
-2,314
-2,365
Net Non Operating Interest Income Expense
-475.118
-245.676
-13.073
2.79
13.89
Other Income Expense
295.033
248.552
348.292
-246.194
91.798
Pretax Income
-4,237
-2,549
-1,751
-2,558
-2,260
Tax Provision
0
0
0
0
-
Net Income Common Stockholders
-4,237
-2,549
-1,751
-2,558
-2,260
Diluted NI Available to Com Stockholders
-4,237
-2,549
-1,751
-2,558
-2,260
Basic EPS
-
-0.25
-0.17
-0.25
-0.22
Diluted EPS
-
-0.25
-0.17
-0.25
-0.22
Basic Average Shares
-
10,339
10,261
10,261
10,261
Diluted Average Shares
-
10,339
10,261
10,261
10,261
Total Operating Income as Reported
-4,057
-2,552
-2,086
-2,314
-2,365
Total Expenses
4,057
2,552
2,086
2,314
2,365
Net Income from Continuing & Discontinued Operation
-4,237
-2,549
-1,751
-2,558
-2,260
Normalized Income
-4,532
-2,797
-2,099
-2,311
-2,351
Interest Income
0.257
0.502
2.813
2.79
13.89
Interest Expense
475.375
246.178
15.886
-
0
Net Interest Income
-475.118
-245.676
-13.073
2.79
13.89
EBIT
-3,762
-2,303
-1,735
-2,314
-2,260
EBITDA
-3,762
-
-
-
-
Reconciled Depreciation
0.121
0.286
0.339
0.347
0.148
Net Income from Continuing Operation Net Minority Interest
-4,237
-2,549
-1,751
-2,558
-2,260
Total Unusual Items Excluding Goodwill
295.033
248.552
348.292
-246.194
91.798
Total Unusual Items
295.033
248.552
348.292
-246.194
91.798
Normalized EBITDA
-4,057
-2,551
-2,083
-2,068
-2,351
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0